Hepatitis Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: H2CFCC872A88EN
Market Monitor Global

Abstracts

Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.

This report contains market size and forecasts of Hepatitis Therapeutics in Global, including the following market information:

Global Hepatitis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hepatitis Therapeutics market was valued at 18420 million in 2021 and is projected to reach US$ 20090 million by 2028, at a CAGR of 1.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hepatitis Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hepatitis Therapeutics include Gilead, Johnson & Johnson, Bristol-Myers Squibb Company, Merck & Co.Inc. and AbbVie Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Hepatitis Vaccine
• Anti-Viral Drugs

Global Hepatitis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hepatitis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hepatitis A
• Hepatitis B
• Hepatitis C
• Alcoholic Hepatitis
• Others

Global Hepatitis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hepatitis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hepatitis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead
• Johnson & Johnson
• Bristol-Myers Squibb Company
• Merck & Co.Inc.
• AbbVie Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Hepatitis Therapeutics Market Size: 2021 VS 2028
2.2 Global Hepatitis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hepatitis Therapeutics Players in Global Market
3.2 Top Global Hepatitis Therapeutics Companies Ranked by Revenue
3.3 Global Hepatitis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Hepatitis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hepatitis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hepatitis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Hepatitis Vaccine
  4.1.3 Anti-Viral Drugs
4.2 By Type - Global Hepatitis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Hepatitis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hepatitis A
  5.1.3 Hepatitis B
  5.1.4 Hepatitis C
  5.1.5 Alcoholic Hepatitis
  5.1.6 Others
5.2 By Application - Global Hepatitis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Hepatitis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Hepatitis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hepatitis Therapeutics Revenue, 2017-2028
  6.3.2 US Hepatitis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Hepatitis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Hepatitis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hepatitis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Hepatitis Therapeutics Market Size, 2017-2028
  6.4.3 France Hepatitis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Hepatitis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Hepatitis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Hepatitis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Hepatitis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Hepatitis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hepatitis Therapeutics Revenue, 2017-2028
  6.5.2 China Hepatitis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Hepatitis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Hepatitis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Hepatitis Therapeutics Market Size, 2017-2028
  6.5.6 India Hepatitis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hepatitis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Hepatitis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Hepatitis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hepatitis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Hepatitis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Hepatitis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Hepatitis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Hepatitis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead
  7.1.1 Gilead Corporate Summary
  7.1.2 Gilead Business Overview
  7.1.3 Gilead Hepatitis Therapeutics Major Product Offerings
  7.1.4 Gilead Hepatitis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Gilead Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Hepatitis Therapeutics Major Product Offerings
  7.2.4 Johnson & Johnson Hepatitis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Bristol-Myers Squibb Company
  7.3.1 Bristol-Myers Squibb Company Corporate Summary
  7.3.2 Bristol-Myers Squibb Company Business Overview
  7.3.3 Bristol-Myers Squibb Company Hepatitis Therapeutics Major Product Offerings
  7.3.4 Bristol-Myers Squibb Company Hepatitis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Company Key News
7.4 Merck & Co.Inc.
  7.4.1 Merck & Co.Inc. Corporate Summary
  7.4.2 Merck & Co.Inc. Business Overview
  7.4.3 Merck & Co.Inc. Hepatitis Therapeutics Major Product Offerings
  7.4.4 Merck & Co.Inc. Hepatitis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co.Inc. Key News
7.5 AbbVie Inc.
  7.5.1 AbbVie Inc. Corporate Summary
  7.5.2 AbbVie Inc. Business Overview
  7.5.3 AbbVie Inc. Hepatitis Therapeutics Major Product Offerings
  7.5.4 AbbVie Inc. Hepatitis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 AbbVie Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hepatitis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Hepatitis Therapeutics Market Drivers in Global Market
Table 3. Hepatitis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Hepatitis Therapeutics in Global Market
Table 5. Top Hepatitis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis Therapeutics Product Type
Table 9. List of Global Tier 1 Hepatitis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hepatitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hepatitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hepatitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Corporate Summary
Table 31. Gilead Hepatitis Therapeutics Product Offerings
Table 32. Gilead Hepatitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Hepatitis Therapeutics Product Offerings
Table 35. Johnson & Johnson Hepatitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company Corporate Summary
Table 37. Bristol-Myers Squibb Company Hepatitis Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Company Hepatitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co.Inc. Corporate Summary
Table 40. Merck & Co.Inc. Hepatitis Therapeutics Product Offerings
Table 41. Merck & Co.Inc. Hepatitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. AbbVie Inc. Corporate Summary
Table 43. AbbVie Inc. Hepatitis Therapeutics Product Offerings
Table 44. AbbVie Inc. Hepatitis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hepatitis Therapeutics Segment by Type in 2021
Figure 2. Hepatitis Therapeutics Segment by Application in 2021
Figure 3. Global Hepatitis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis Therapeutics Revenue in 2021
Figure 8. By Type - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Hepatitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Hepatitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company Hepatitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co.Inc. Hepatitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AbbVie Inc. Hepatitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)